Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (191-200 of 2,279) with videos related to

Pageof 228
Sort By:
Nature Reviews. Nephrology|February 11, 2015
Anticoagulation therapy: Balancing the risks of stroke and bleeding in CKDArman Qamar, Deepak L Bhatt
Contemporary Clinical Trials|April 18, 2022
Evaluating the evaluators - Developing evidence of quality oversight effectiveness for clinical trial monitoring: Source data verification, source data review, statistical monitoring, key risk indicators, and direct measure of high risk errorsPenelope Manasco, Deepak L Bhatt
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fightDeepak L Bhatt, Eric J Topol
Cleveland Clinic Journal of Medicine|May 23, 2002
The CURE trial: using clopidogrel in acute coronary syndromes without ST-segment elevationGregory P Gerschutz, Deepak L Bhatt
JACC. Cardiovascular Imaging|March 21, 2021
The Emerging Role of Coronary Computed Tomography Angiography in Stable Angina With ISCHEMIADeepak L Bhatt, Benjamin E Peterson
Eclinicalmedicine|September 6, 2021
Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic AcidsSafi U Khan, Deepak L Bhatt
JACC. Cardiovascular Imaging|March 11, 2017
Out With the Old Rule-Out: Raising the Bar for Acute Chest Pain Evaluation With Randomized Trials of Cardiac ImagingDeepak L Bhatt, Viviany R Taqueti
Herz|September 2, 2004
Management of acute coronary syndrome in diabetes mellitusJim M John, Deepak L Bhatt
European Heart Journal|September 24, 2019
THEMIS and THEMIS-PCIDeepak L Bhatt, Philippe Gabriel Steg
European Heart Journal|November 4, 2021
The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethylPh Gabriel Steg, Deepak L Bhatt
Pageof 228

Showing results (191-200 of 2,279) with videos related to

Sort By:
Pageof 228
Nature Reviews. Nephrology|February 11, 2015
Anticoagulation therapy: Balancing the risks of stroke and bleeding in CKDArman Qamar, Deepak L Bhatt
Contemporary Clinical Trials|April 18, 2022
Evaluating the evaluators - Developing evidence of quality oversight effectiveness for clinical trial monitoring: Source data verification, source data review, statistical monitoring, key risk indicators, and direct measure of high risk errorsPenelope Manasco, Deepak L Bhatt
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fightDeepak L Bhatt, Eric J Topol
Cleveland Clinic Journal of Medicine|May 23, 2002
The CURE trial: using clopidogrel in acute coronary syndromes without ST-segment elevationGregory P Gerschutz, Deepak L Bhatt
JACC. Cardiovascular Imaging|March 21, 2021
The Emerging Role of Coronary Computed Tomography Angiography in Stable Angina With ISCHEMIADeepak L Bhatt, Benjamin E Peterson
Eclinicalmedicine|September 6, 2021
Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic AcidsSafi U Khan, Deepak L Bhatt
JACC. Cardiovascular Imaging|March 11, 2017
Out With the Old Rule-Out: Raising the Bar for Acute Chest Pain Evaluation With Randomized Trials of Cardiac ImagingDeepak L Bhatt, Viviany R Taqueti
Herz|September 2, 2004
Management of acute coronary syndrome in diabetes mellitusJim M John, Deepak L Bhatt
European Heart Journal|September 24, 2019
THEMIS and THEMIS-PCIDeepak L Bhatt, Philippe Gabriel Steg
European Heart Journal|November 4, 2021
The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethylPh Gabriel Steg, Deepak L Bhatt
Pageof 228